INTRODUCTION Human skin provides vital protection from water loss and from external insult
through structural adaptations and interplay with the innate and adaptive immune systems…

Drug survival reflects a drug’s effectiveness, safety, and tolerability. We assessed the drug
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …

Background Atopic eczema affects 1–2% of adults, and can cause considerable morbidity.
We aimed to assess the safety and efficacy of azathioprine as systemic monotherapy for …

Background Narrow-band ultraviolet B (UVB) is an effective treatment for psoriasis, and open
studies suggest that this phototherapy might improve atopic eczema. We did a randomised …

Importance Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally
because of their ability to ameliorate shared immune pathways across immune-mediated …

Background Although most patients with atopic dermatitis (AD) are effectively managed with
topical medication, a significant minority require systemic therapy. Guidelines for decision …

Background Immunosuppressive treatments inhibit vaccine-induced immunity against SARS-CoV-2.
We evaluated whether a 2-week interruption of methotrexate treatment immediately …

Group 2 innate lymphoid cells (ILC-2s) regulate immune responses to pathogens and maintain
tissue homeostasis in response to cytokines. Positive regulation of ILC-2s through ICOS …

Importance Drug survival of biologic therapies for psoriasis is a proxy for longer-term
treatment effectiveness and safety. Patient factors that are associated with the survival of each …

BACKGROUND: Null mutations within the filaggrin gene (FLG) are associated with
moderate-to-severe atopic eczema; their role in the mild-to-moderate eczema present in the general …